Siemens Biomarker Multi-modality Study for Fatty Liver
This study is looking at how well new imaging technologies, Photon-counting CT (PCCT) and Ultrasound, can find fat and scarring in the liver. These results will be compared to Magnetic Resonance Imaging (MRI), which is considered the standard. You would receive a regular CT scan using the PCCT scanner, plus a few extra pictures for the study. You would also have an MRI and an Ultrasound. If needed, you might also have a blood test. This study is for adults aged 18 or older with certain liver conditions who are already scheduled for a CT scan of the liver and are eligible for MRI. The study aims to see how accurate PCCT and Ultrasound are at detecting liver fat within 1 to 14 days.
- Study design
- This is an interventional study planning to enroll 45 participants. It compares different imaging techniques to a standard MRI.
- What's involved
- You would undergo a Photon-counting CT scan, an MRI, and an Ultrasound. You might also have a blood test if you haven't had one recently.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures the accuracy of the imaging tests within 1 to 14 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Siemens Biomarker Multi-modality
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Mustafa Bashir, MD · PRINCIPAL_INVESTIGATOR · Duke University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Sensitivity of CT-FF (computed tomography fat fraction)1 day to 14 days
The percentage of patients with hepatic steatosis by MRI-PDFF who have positive CT-PDFF.
- Specificity of CT-FF (computed tomography fat fraction)1 day to 14 days
The percentage of patients without hepatic steatosis by MRI-PDFF who have negative CT-PDFF.